Detection of the ΔF508 (F508del) mutation of the cystic fibrosis gene by surface plasmon resonance and biosensor technology

In the present paper, we applied surface plasmon resonance (SPR) and biosensor technologies for biospecific interaction analysis (BIA) to detect ΔF508 mutation (F508del) of the cystic fibrosis transmembrane regulator (CFTR) gene in both homozygous as well as heterozygous human subjects. The proposed method is divided into three major steps. The first step is the immobilization on a SA5 sensor chip of two biotinylated oligonucleotide probes (one normal, N‐508, and the other mutant, ΔF508) that are able to hybridize to the CFTR gene region involved in F508del mutation. The second step consists of the molecular hybridization between the oligonucleotide probes immobilized on the sensor chips and (1) wild‐type or mutant oligonucleotides, as well as (2) single‐stranded DNA obtained by asymmetric polymerase chain reaction (PCR), performed using genomic DNA from normal individuals and from F508del heterozygous and F508del homozygous patients. The third, and most important, step consists of the evaluation of differential stabilities of DNA/DNA molecular complexes generated after hybridization of normal and ΔF508 probes immobilized on the sensor chips. The results obtained strongly suggest that the proposed procedure employing SPR technology enables a one‐step, nonradioactive protocol for the molecular diagnosis of F508del mutation of the CFTR gene. This approach could be of interest in clinical genetics, as the hybridization step is oftenly required to detect microdeletions present within PCR products. Hum Mutat 13:390–400, 1999. © 1999 Wiley‐Liss, Inc.

[1]  R Gambari,et al.  Biosensor technology and surface plasmon resonance for real-time detection of HIV-1 genomic sequences amplified by polymerase chain reaction. , 1997, Clinical and diagnostic virology.

[2]  L. Tsui,et al.  Erratum: Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNA , 1989, Science.

[3]  T. Sekiya,et al.  Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[4]  J. Clegg,et al.  Detection of the Factor V Leiden Mutation Using Whole Blood PCR , 1996, Thrombosis and Haemostasis.

[5]  R. Karlsson,et al.  Surface plasmon resonance detection and multispot sensing for direct monitoring of interactions involving low-molecular-weight analytes and for determination of low affinities. , 1995, Analytical biochemistry.

[6]  P. Nilsson,et al.  Real-time monitoring of DNA manipulations using biosensor technology. , 1995, Analytical biochemistry.

[7]  K. Mullis,et al.  Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. , 1985, Science.

[8]  J. Harper,et al.  CLINICAL EXPERIENCE WITH PREIMPLANTATION GENETIC DIAGNOSIS OF CYSTIC FIBROSIS (ΔF508) , 1996 .

[9]  S. Antonarakis Recommendations for a nomenclature system for human gene mutations , 1998 .

[10]  R. Gambari,et al.  Use of an automated laboratory workstation for isolation of genomic DNA suitable for PCR and allele-specific hybridization. , 1993, BioTechniques.

[11]  D. Fink,et al.  Rapid construction of deleted DNA fragments for use as internal standards in competitive PCR. , 1994, PCR methods and applications.

[12]  R. Gibbs,et al.  PCR test for cystic fibrosis deletion , 1990, Nature.

[13]  M. Uhlén,et al.  Detection of mutations in PCR products from clinical samples by surface plasmon resonance , 1997, Journal of molecular recognition : JMR.

[14]  L. Tsui,et al.  Erratum: Identification of the Cystic Fibrosis Gene: Genetic Analysis , 1989, Science.

[15]  F. Collins,et al.  Two frameshift mutations in the cystic fibrosis gene. , 1991, American journal of human genetics.

[16]  S. Wood DNA-DNA Hybridization in Real Time Using BIAcore , 1993 .

[17]  D. Garling,et al.  Rapid cycle DNA amplification: time and temperature optimization. , 1991, BioTechniques.

[18]  R. Karlsson,et al.  Real-time biospecific interaction analysis using surface plasmon resonance and a sensor chip technology. , 1991, BioTechniques.

[19]  C. Férec,et al.  Detection of over 98% cystic fibrosis mutations in a Celtic population , 1992, Nature Genetics.

[20]  L. Tsui,et al.  Methods for analysis of multiple cystic fibrosis mutations , 1991, Human Genetics.

[21]  Michael Dean,et al.  A frame-shift mutation in the cystic fibrosis gene , 1990, Nature.

[22]  J. Wall,et al.  Detection of multiple cystic fibrosis mutations by reverse dot blot hybridization: a technology for carrier screening , 1992, Human Genetics.

[23]  Magnus Malmqvist,et al.  Biospecific interaction analysis using biosensor technology , 1993, Nature.

[24]  R. Gambari,et al.  Polymerase-chain reaction: analysis of DNA/DNA hybridization by capillary electrophoresis. , 1993, Nucleic acids research.

[25]  C. Coutelle,et al.  Identification of three novel mutations in the CFTR gene using temperature-optimized non-radioactive conditions for SSCP analysis , 1994, Human Genetics.

[26]  P. Pignatti,et al.  Screening of 62 mutations in a cohort of cystic fibrosis patients from north eastern Italy: Their incidence and clinical features of defined genotypes , 1993, Human mutation.

[27]  B. Kerem,et al.  Association of a nonsense mutation (W1282X), the most common mutation in the Ashkenazi Jewish cystic fibrosis patients in Israel, with presentation of severe disease. , 1992, American journal of human genetics.

[28]  B. Dallapiccola,et al.  Molecular characterization of a frameshift mutation in exon 19 of the CFTR gene , 1993, Human mutation.

[29]  L. Tsui,et al.  Rapid nonradioactive detection of the major cystic fibrosis mutation. , 1990, American journal of human genetics.

[30]  F. Collins,et al.  Identification of mutations in regions corresponding to the two putative nucleotide (ATP)-binding folds of the cystic fibrosis gene. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Pankaj Vadgama,et al.  Biosensors: recent trends. A review , 1992 .

[32]  M. Uhlén,et al.  Rapid colorimetric quantification of PCR-amplified DNA. , 1991, BioTechniques.

[33]  M. White,et al.  A deletion of two nucleotides in exon 10 of the CFTR gene in a Soviet family with cystic fibrosis causing early infant death. , 1991, Genomics.

[34]  K. Klinger,et al.  Multiplex PCR amplification from the CFTR gene using DNA prepared from buccal brushes/swabs. , 1993, Human molecular genetics.